Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1274717

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of the Pfizer/BioNTech covid-19 vaccine if the second dose is administered 12 weeks after the first dose.
tabling member constituency	Manchester, Gorton
tabling member printed	Afzal Khan
uin	134547
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>A recent study demonstrated a two-dose vaccine efficacy of 95% for the Pfizer/Biotech COVID-19 vaccine, with a second dose delivered between 19 and 42 days. The Joint Committee on Vaccination and Immunisation (JCVI) has reviewed evidence on the Pfizer/BioNTech COVID-19 vaccine and advised an interval of up to 12 weeks between doses. The considerations of the JCVI on extended intervals has been published, and is available here: <a href="https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement" target="_blank">https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement</a></p><p>Using data available from clinical trials, Public Health England estimated that vaccine efficacy from the first dose of the Pfizer/BioNTech vaccine is approximately 89%. This is the efficacy calculated 15 to 21 days after the first dose. The estimate for 15 to 28 days is 91% which includes seven days after the second dose, but is prior to the time protection that may be expected from the second dose. There is no estimate of efficacy for a single dose beyond 21 days, but the JCVI’s view is that protective immunity from the first dose likely lasts for a duration of 12 weeks.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 134548 134549 question first answered 18/01/2021 11:48:46 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73470 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4671 label Biography information for Afzal Khan

1274718

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of the Pfizer/BioNTech covid-19 vaccine if the second dose is administered three weeks after the first dose.
tabling member constituency	Manchester, Gorton
tabling member printed	Afzal Khan
uin	134548
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>A recent study demonstrated a two-dose vaccine efficacy of 95% for the Pfizer/Biotech COVID-19 vaccine, with a second dose delivered between 19 and 42 days. The Joint Committee on Vaccination and Immunisation (JCVI) has reviewed evidence on the Pfizer/BioNTech COVID-19 vaccine and advised an interval of up to 12 weeks between doses. The considerations of the JCVI on extended intervals has been published, and is available here: <a href="https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement" target="_blank">https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement</a></p><p>Using data available from clinical trials, Public Health England estimated that vaccine efficacy from the first dose of the Pfizer/BioNTech vaccine is approximately 89%. This is the efficacy calculated 15 to 21 days after the first dose. The estimate for 15 to 28 days is 91% which includes seven days after the second dose, but is prior to the time protection that may be expected from the second dose. There is no estimate of efficacy for a single dose beyond 21 days, but the JCVI’s view is that protective immunity from the first dose likely lasts for a duration of 12 weeks.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 134547 134549 question first answered 18/01/2021 11:48:46 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73466 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4671 label Biography information for Afzal Khan

1274719

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will publish the evidence for the decision to administer the second dose of the Pfizer/BioNTech covid-19 vaccine 12 weeks after the first dose.
tabling member constituency	Manchester, Gorton
tabling member printed	Afzal Khan
uin	134549
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>A recent study demonstrated a two-dose vaccine efficacy of 95% for the Pfizer/Biotech COVID-19 vaccine, with a second dose delivered between 19 and 42 days. The Joint Committee on Vaccination and Immunisation (JCVI) has reviewed evidence on the Pfizer/BioNTech COVID-19 vaccine and advised an interval of up to 12 weeks between doses. The considerations of the JCVI on extended intervals has been published, and is available here: <a href="https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement" target="_blank">https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement</a></p><p>Using data available from clinical trials, Public Health England estimated that vaccine efficacy from the first dose of the Pfizer/BioNTech vaccine is approximately 89%. This is the efficacy calculated 15 to 21 days after the first dose. The estimate for 15 to 28 days is 91% which includes seven days after the second dose, but is prior to the time protection that may be expected from the second dose. There is no estimate of efficacy for a single dose beyond 21 days, but the JCVI’s view is that protective immunity from the first dose likely lasts for a duration of 12 weeks.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 134547 134548 question first answered 18/01/2021 11:48:45 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73464 answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4671 label Biography information for Afzal Khan

1274747

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what role community pharmacies will have in the delivery of the covid-19 vaccine.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	134411
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>Community pharmacies will play a major role in the COVID-19 vaccination programme. Since 11 January 2021, some community pharmacies have started to offer the COVID-19 vaccination service, with more pharmacies joining the service over the coming weeks.</p><p>Some pharmacists and members of their team have been working with general practitioners to deliver the vaccine in many areas of the country as part of the Primary Care Network service.</p><p>The Department, NHS England and NHS Improvement, and the community pharmacy representative bodies will be working together to establish how community pharmacies’ role could be expanded further in the vaccination programme.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/01/2021 12:14:16 answering member 4113 label Biography information for Nadhim Zahawi previous answer version 73483 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380
tabling member	3973 label Biography information for Grahame Morris

1274784

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Leicestershire
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to support community pharmacies in Leicestershire with the roll-out of covid-19 vaccinations.
tabling member constituency	Bosworth
tabling member printed	Dr Luke Evans
uin	134604
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>Community pharmacies providing the COVID-19 vaccination, regardless of their location in England, will be eligible for support in the form of training, funding for the service including fee per vaccination, additional venue hire costs and pre-agreed one off set up costs and non-monetary support - for example, access to vaccines, consumables, personal protective equipment and other equipment to operate the site.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/01/2021 09:18:21 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4781 label Biography information for Dr Luke Evans

1274918

registered interest
date	08/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Covid Pass
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of a covid-19 vaccine passport.
tabling member constituency	Newport West
tabling member printed	Ruth Jones
uin	134566
answer	answer is ministerial correction date of answer 19/01/2021 answer text <p>We have no plans to introduce COVID-19 vaccine passports. As with other vaccination programmes, vaccine record cards are issued to patients with the relevant details about the vaccine including the date of their vaccination and their vaccine type. This does not constitute an immunity passport and will not be used as a form of identification.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 19/01/2021 11:09:33 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4716 label Biography information for Ruth Jones

1273110

registered interest
date	06/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Iron and Steel: UK Trade with EU
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, with reference to the Northern Ireland protocol, what steps his Department is taking to ensure that UK steel companies can export into the EU without facing EU Safeguard Tariffs.
tabling member constituency	Aberavon
tabling member printed	Stephen Kinnock
uin	132930
answer	answer is ministerial correction date of answer 20/01/2021 answer text <p>The Government has worked successfully with the European Commission to secure country-specific allocations for various steel products within the Tariff Rate Quotas (by which the EU imposes its steel safeguard measures) to enable UK companies to trade tariff-free into the EU. These tariff-free allocations came into operation on 1 January 2021. Officials in the Department for International Trade continue to discuss the size and applicability of these quotas with the European Commission.</p><p>For steel traded into Northern Ireland, there is an interim solution already in place for steel from Britain and the EU to ensure it enters tariff free.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 20/01/2021 16:49:00 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4359 label Biography information for Stephen Kinnock

1273750

registered interest
date	06/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the locations are of the GP surgeries that are administering the covid-19 vaccine.
tabling member constituency	Hemsworth
tabling member printed	Jon Trickett
uin	133696
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>As of 10 January 2021, 785 local vaccination services were available to administer the vaccine. The designated site names and regions of these services and their associated clinical commissioning groups can be found at the following link:</p><p><a href="https://www.england.nhs.uk/coronavirus/hospital-hubs-and-local-vaccination-services/" target="_blank">https://www.england.nhs.uk/coronavirus/hospital-hubs-and-local-vaccination-services/</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 18/01/2021 12:08:29 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	410 label Biography information for Jon Trickett

1273801

registered interest
date	06/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what the existing weekly capacity for vaccine production is in the UK.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	133636
answer	answer is ministerial correction date of answer 15/01/2021 answer text <p>The UK has a strong manufacturing basis in vaccines and life sciences, with a range of sites around the country.</p><p> </p><p>Through the Vaccine Taskforce, the Government has entered commercial arrangements with a number of these sites to manufacture and fill-finish COVID-19 vaccines. The Government has also invested over £230 million in expanding the UK’s vaccine manufacturing base, through several investments, such as the Vaccines Manufacturing and Innovation Centre and Cell and Gene Manufacturing and Innovation Centre.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/01/2021 14:14:44 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	318 label Biography information for John Spellar

1273936

registered interest
date	06/01/2021
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Clothing and Textiles: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what plans his Department has to support the UK's fashion and textile industry to rebuild following the covid-19 outbreak.
tabling member constituency	East Kilbride, Strathaven and Lesmahagow
tabling member printed	Dr Lisa Cameron
uin	133903
answer	answer is ministerial correction date of answer 15/01/2021 answer text <p>The Government continues to offer a comprehensive support package for businesses including loan schemes, grant funding, tax deferrals, the Self-Employment Income Support Scheme and the Coronavirus Job Retention Scheme, all of which have been designed to be accessible to businesses in most sectors and across the UK.</p><p>On 5 January, my Rt. Hon. Friend Mr Chancellor of the Exchequer announced a £594 million discretionary fund to support other impacted businesses outside of the retail, hospitality, and leisure sectors, which is in addition to £1.1 billion further discretionary grant funding for Local Authorities and Local Restriction Support Grants worth up to £3,000 a month.</p><p>Ministers and officials in the Department and across Government continue to regularly engage with the fashion and textiles industry to explore ways in which Government can support long term recovery in the sector.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 15/01/2021 11:30:22 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4412 label Biography information for Dr Lisa Cameron